Sakar Healthcare Limited (SAKAR) — Financial Results | 20 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board meeting scheduled to approve unaudited Q1 FY27 results
💡 Investor Takeaway
The filing signals upcoming financial results disclosure, but provides no performance metrics or outlook.

Sakar Healthcare Limited announced a board meeting on 24 July 2026 to approve unaudited financial results for the quarter ended 30 June 2026, with trading window restrictions applying until 48 hours post-results announcement.

📄 View Original Announcement (PDF)

About Sakar Healthcare Limited (SAKAR)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,550.15 Cr P/E: 102.3

View full SAKAR stock details →

📡 Get AI alerts when SAKAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SAKAR — Free

📊 More SAKAR filings

See all SAKAR filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SAKAR files new disclosures

Track SAKAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SAKAR — Free

Free account · 2 AI queries/day